Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PRISM BioLab Co.,LTD
No Price
Closing Price XTKS 28.04.2026:
184,00 JPY
28.04.2026 06:30
Current Prices from PRISM BioLab Co.,LTD
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
206A.T
JPY
28.04.2026 06:30
184,00 JPY
4,00 JPY
+2,22 %
Share Float & Liquidity
Free Float48,77 %
Shares Float18 M
Shares Outstanding36,92 M
Company Profile for PRISM BioLab Co.,LTD Share
PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.
